HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR

Abstract: disclosed in the present invention is a new 11-oxo-7,11-dihydro-6h-benzo-[f]pyrido[1,2-d][1,4]azepine oxepin-10-carboxylic acid derivative serving as a hepatitis b virus surface antigen inhibitor. specifically disclosed are a compound represented by formula (v) or a pharmaceutically acceptable salt thereof, and applications of the compound represented by formula (v) or the pharmaceutically acceptable salt thereof and a pharmaceutical composition thereof in the treatment of viral hepatitis b.

Inventor(s): Charles Z. DING, Fei SUN, Yanbin HU, Shuhui CHEN

CPC Classification: C07D498/04 (HETEROCYCLIC COMPOUNDS (macromolecular compounds ))

Search for rejections for patent application number 20250154166